HTG Molecular Diagnostics, Inc. appoints Jerald Radich as member of Therapeutics Scientific Advisory Board
December 16, 2021 at 04:05 pm
HTG Molecular Diagnostics, Inc. announced that internationally renowned physician-scientist Jerald Radich, M.D., a pioneer in the fields of leukemia research and molecular genetics, has joined the companys Therapeutics Scientific Advisory Board. Dr. Radich adds to the companys growing group of esteemed advisors as the company continues to expand its therapeutics division activities targeting disruption of the existing drug discovery process.